John Baladakis1,2,3, Marlon Perera4,5, Damien Bolton4,6, Nathan Lawrentschuk4,6,7, Ahmed Adam1,2,3. 1. Department of Urology, Helen Joseph Hospital, University of the Witwatersrand, Johannesburg, South Africa. 2. Department of Pediatric Urology, Rahima Moosa Mother & Child (Coronation) Hospital, University of the Witwatersrand, Johannesburg, South Africa. 3. Division of Urology, Department of Surgery, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa. 4. Department of Surgery, Austin Health, University of Melbourne, Melbourne, VIC. 5. Department of Surgery, University of Queensland, Brisbane, QLD. 6. Olivia-Newton John Cancer Centre, University of Melbourne, Melbourne, VIC. 7. Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Abstract
AIMS: We aimed to compare the outcome of curative treatment options in localised Prostate Cancer (PCa) amongst HIV positive (HIV+) men. METHODS: A systematic search of the Cochrane Library of Systematic Reviews, the Scopus and PubMed databases was performed (January 1995 to November 2015) using pre-determined search terms. Outcome measures for comparison included the rate of biochemical failure (BCF), survival benefit and complications. RESULTS: A total of 14 eligible articles were identified for inclusion, representing a total of 202 HIV+ men with PCa. Radical Prostatectomy was performed in 40/153 compared to 109/153 patients undergoing alternative (non-surgical) treatments options. Only 3 studies compared outcomes within their respective study cohort. One study (n = 10) reported BCF results with 1/2 BCF patient in the surgical arm vs. 1/8 BCF positive patients in the non-surgical arm (mean 46 months follow-up), while two other studies reported no occurrences of BCF within both arms of their studies. CONCLUSION: Due to paucity in the literature, there is insufficient evidence to support a certain treatment modality arm specifically for HIV+ men with localized PCa. An individualized management algorithm seems feasible within this cohort, until more definitive studies are performed.
AIMS: We aimed to compare the outcome of curative treatment options in localised Prostate Cancer (PCa) amongst HIV positive (HIV+) men. METHODS: A systematic search of the Cochrane Library of Systematic Reviews, the Scopus and PubMed databases was performed (January 1995 to November 2015) using pre-determined search terms. Outcome measures for comparison included the rate of biochemical failure (BCF), survival benefit and complications. RESULTS: A total of 14 eligible articles were identified for inclusion, representing a total of 202 HIV+ men with PCa. Radical Prostatectomy was performed in 40/153 compared to 109/153 patients undergoing alternative (non-surgical) treatments options. Only 3 studies compared outcomes within their respective study cohort. One study (n = 10) reported BCF results with 1/2 BCF patient in the surgical arm vs. 1/8 BCF positive patients in the non-surgical arm (mean 46 months follow-up), while two other studies reported no occurrences of BCF within both arms of their studies. CONCLUSION: Due to paucity in the literature, there is insufficient evidence to support a certain treatment modality arm specifically for HIV+ men with localized PCa. An individualized management algorithm seems feasible within this cohort, until more definitive studies are performed.
Authors: Julia J van Tol-Geerdink; Jan Willem Leer; Philip C Weijerman; Inge M van Oort; Henk Vergunst; Emile N van Lin; J Alfred Witjes; Peep F Stalmeier Journal: BJU Int Date: 2012-08-10 Impact factor: 5.588
Authors: Tracy Ng; Nicholas F Stein; Jed Kaminetsky; Steven Berman; Hillel Y Marans; Bill McDermott; Anthony M Berson Journal: Urology Date: 2008-04-14 Impact factor: 2.649
Authors: Christopher J D Wallis; Refik Saskin; Richard Choo; Sender Herschorn; Ronald T Kodama; Raj Satkunasivam; Prakesh S Shah; Cyril Danjoux; Robert K Nam Journal: Eur Urol Date: 2015-12-15 Impact factor: 20.096